Evidence map›Paper›PMID 42477470›Full record

ArticleCommunications biology2026

Prohibitin 2 is a key regulator of T cell proliferation, differentiation, and effector functions in vivo.

Johannes F Vogt, Carsten Merkwirth, Petra Adams-Quack, Elena Zurkowski, Emmanouill Stylianakis, David C Uhlfelder, Thomas Michna, Assel Nurbekova, Ute Distler, Liliana Rojas-Charry and 9 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Johannes F Vogt *Institute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Carsten Merkwirth *Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.ORCID 0000-0001-8895-3495
Petra Adams-QuackInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Elena ZurkowskiInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Emmanouill StylianakisInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
David C UhlfelderInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Thomas MichnaResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Assel NurbekovaResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0009-0000-2106-9179
Ute DistlerResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-8031-6384
Liliana Rojas-CharryInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Hajime YurugiCell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Sonja ReißigInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
F Thomas WunderlichMax Planck Institute for Metabolism Research Cologne, Cologne, Germany.
Krishnaraj RajalingamCell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-4175-9633
Stefan TenzerResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0003-3034-0017
Axel MethnerInstitute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-8774-0057
Thomas LangerMax Planck Institute for Biology of Ageing, Cologne, Germany.ORCID 0000-0003-1250-1462
Ari Waisman *Institute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0003-4304-8234
Nadine Hövelmeyer *Institute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. hoevelme@uni-mainz.de.ORCID 0000-0002-1807-4556

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 318346496Deutsche Forschungsgemeinschaft (German Research Foundation) 490846870
6 · The paper itself

Abstract

Prohibitin 2 (PHB2) is a highly conserved protein with essential roles in cell homeostasis and survival across different cell types. Previous studies have shown that the deletion of PHB2 results in an arrest in proliferation due to impaired mitochondrial function regulated by the dynamin-like GTPase OPA1. The function of PHB2 in immune cells remains unclear; however, some studies suggest that PHB2 plays a role in the cell membranes of B and T cells. In order to elucidate the role of PHB2 in immune cells, we generated PHB2-deficient T cells. Our findings reveal a pivotal role for PHB2 in the proliferation and differentiation of T cells. PHB2 deficiency inhibits T cell proliferation by inducing a cell cycle arrest at the G1 to S phase, thereby preventing the differentiation into effector T cells. Furthermore, in contrast to previous reports, T cells lacking PHB2 are more resistant to apoptosis. Metabolic analysis reveals that PHB2-deficient T cells fail to boost their energy production through glycolysis and oxidative phosphorylation upon activation, hindering their ability to sustain biosynthetic processes and to proliferate in response to activation.

Indexed as

Cell DifferentiationCell ProliferationRepressor ProteinsT-LymphocytesAnimalsApoptosisLymphocyte ActivationMiceMice, KnockoutProhibitinsPhb2 protein, mouseProhibitinsRepressor Proteins

Identifiers

PMID42477470
PMCPMC13385934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.